Innovotech Inc.IOT.V

Health Care · Pharmaceuticals, Biotechnology & Life Sciences · TSX-V · Canada · innovotech.ca

Innovotech Inc. is a diversified life sciences technology company specializing in applied microbiology, analytical chemistry, and regulated laboratory services. The company provides antimicrobial assay kits, contract research services, and antimicrobial testing for applications in medical devices, pharmaceutical development, wound healing, and food safety. Its subsidiaries include Innovotech Labs Corporation and Keystone Labs, and it holds a 60% interest in NouLife Sciences Inc., which focuses on linked antioxidant molecules for skincare and medical treatments.

Key ratios

EPS growth

-62.8%TTM

2025 -62.8%

FCF / Sales

-24.1%TTM

2025 -11.7%2024 -12.9%2023 -22.9%

Net margin

-9.2%TTM

2025 2.1%2024 10.2%2023 -13.3%

ROA

-7.0%TTM

2025 0.4%2024 1.4%2023 -19.5%

ROE

-12.7%TTM

2025 2.8%2024 11.9%2023 -15.3%

Revenue growth

32.5%TTM

2025 106.7%2024 85.6%2023 5.1%

Recent news

Innovotech Inc. Announces CFO Transition and Reports 2026 Annual General Meeting Results 2026-06-17 · Innovotech Inc Innovotech Inc. Reports Q1 2026 Financial Results and Operational Update 2026-05-12 · Innovotech Inc

Track IOT.V in your journal

Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.

Create a free account

Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer